Bayer Q1 EBITDA Rises 9% as Crop Science Sales Reach €7.56 Billion
13 May 2026, Leverkusen: Bayer reported higher first-quarter earnings for 2026, supported by growth in its Crop Science business, particularly soybean and corn
Read MoreFind the latest news, research, product launches, financial results, investments, partnerships, regulatory developments, and business updates from Bayer. Stay informed on Crop Science, pharmaceuticals, consumer health, crop protection, seeds, biologicals, digital agriculture, healthcare, sustainability, and global business developments.
Bayer AG is a global life science company headquartered in Leverkusen, Germany, operating through three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Its businesses develop products and technologies across agriculture and healthcare, with the company focused on addressing challenges related to food security, climate change, disease prevention, and healthcare access. Bayer’s global portfolio includes seeds, biotechnology traits, crop protection products, digital agriculture solutions, prescription medicines, and consumer healthcare brands.
The Crop Science division is particularly relevant to agriculture, with activities spanning seeds and traits, herbicides, fungicides, insecticides, biologicals, digital farming, and agricultural research. Bayer is advancing a pipeline of new agricultural products while focusing on technologies designed to improve farm productivity, resource efficiency, and resilience. Its current agricultural strategy includes a portfolio of ten planned blockbuster launches.
In India, Bayer has been present for more than 130 years and operates through businesses including Crop Science, Pharmaceuticals and Consumer Health. Bayer CropScience Limited is the group’s listed Indian Crop Science company, with activities covering crop protection, seeds, traits, biologicals and digital farming. The India Crop Science business works with more than 30 million smallholder farmers and focuses on crops including rice, corn, cotton, fruits and vegetables.
Bayer’s global developments in 2026 include Crop Science innovation, financial performance, product pipeline advancement, agricultural technology, sustainability, glyphosate litigation, and strategic investments. The company reported higher Crop Science sales and substantial earnings growth in both the first and second quarters of 2026.
This category features Bayer news, Crop Science, Bayer CropScience India, crop protection, seeds, herbicides, fungicides, insecticides, biologicals, digital agriculture, product launches, R&D, financial results, regulatory developments, sustainability, glyphosate, leadership, investments, partnerships, and global agriculture and healthcare developments.
13 May 2026, Leverkusen: Bayer reported higher first-quarter earnings for 2026, supported by growth in its Crop Science business, particularly soybean and corn
Read MoreBill Anderson, Chairman of the Board of Management (CEO) of Bayer AG 12 May 2026, US: Two months ago, we presented our plan
Read More12 May 2026, Leverkusen: The Bayer Group has reported a solid performance across all divisions for the first quarter of 2026. “We’re pleased
Read More29 April 2026, Berlin: A new report by Leaps by Bayer, Boston Consulting Group (BCG), and Ipsos UK provides a deeper
Read More28 April 2026, Monheim Am Rhein: Bayer is pleased to announce the delivery of high-quality vegetable and corn seed to communities
Read More“We see great progress, but the work isn’t complete yet” 25 April 2026, Leverkusen: The Bayer Group continues to make headway
Read MoreTwo local currency loans of $500,000 each from the Food Systems Innovation Finance Facility to Omia Agribusiness in Uganda and
Read More21 April 2026, Nigeria: The International Institute of Tropical Agriculture (IITA) and Bayer today announced a comprehensive research collaboration agreement focused
Read More30 March 2026, AU: Bayer is proud to partner with the National Cotton Council on Plant Not Plastic, a new initiative
Read More14 March 2026, AU: For our ANZ Consumer Health team, it shapes how we develop products and how we show up
Read More